This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n11http://linked.opendata.cz/resource/drugbank/drug/DB07213/identifier/pdb/
n12http://linked.opendata.cz/resource/drugbank/drug/DB07213/identifier/pubchem-compound/
n8http://bio2rdf.org/drugbank:
n10http://linked.opendata.cz/resource/drugbank/drug/DB07213/identifier/pubchem-substance/
n14http://linked.opendata.cz/resource/drugbank/drug/DB07213/identifier/drugbank/
admshttp://www.w3.org/ns/adms#
n7http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n13http://linked.opendata.cz/resource/drugbank/drug/DB07213/identifier/chemspider/

Statements

Subject Item
n2:DB07213
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n7:DB07213 n8:DB07213
dcterms:title
(5-{3-[5-(PIPERIDIN-1-YLMETHYL)-1H-INDOL-2-YL]-1H-INDAZOL-6-YL}-2H-1,2,3-TRIAZOL-4-YL)METHANOL
adms:identifier
n10:99443684 n11:710 n12:16058617 n13:22376375 n14:DB07213
n3:IUPAC-Name
n4:271B5527-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B552D-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B552C-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B5529-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B552A-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B552B-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B5525-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B5523-363D-11E5-9242-09173F13E4C5 n4:271B5526-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B5524-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B5533-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B5534-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B552E-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B552F-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B5531-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B5530-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B5532-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B5539-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B553B-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B553C-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B5538-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B5537-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B553A-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B5528-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B5535-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B5536-363D-11E5-9242-09173F13E4C5